Join the Oncology Voice Network. Join for Free
Diversity in Medical Affairs and the Power of Networking
networking in medical affairs DEMA mission career advancement tips medical affairs professionals diversity in medical affairs

Diversity in Medical Affairs and the Power of Networking


Share This Article


Summary

In this episode, Tom Caravela welcomes guests Rachel Kennedy, Lashondra Taylor, and Nirav Shah to discuss the formation and mission of DEMA. They explore the transformative power of networking, sharing Rachel's inspiration behind DEMA and how to engage with the organization. The conversation includes networking success stories and valuable advice for new MSLs and job seekers. The guests outline DEMA's current initiatives and future plans, highlighting upcoming events. The episode concludes with updates from Tom and expressions of appreciation for the listeners' support.

My guests today are Rachel Kennedy, LaShaundra Taylor, and Nirav Shah from DiMA (Diversity in Medical Affairs) and we discuss the story of DiMA and the power of networking.

In this episode we discuss:

  • Intro of Rachel, LaShaundra, and Nirav
  • The story of how the DiMA group was formed
  • What is the mission and how can people join or get involved?
  • Their advice for medical affairs professionals on networking and how it can advance their career
  • Examples of how networking has helped them in their careers.
  • Other advice to those that are looking to build a career in Medical Affairs

Click for Source
networking in medical affairs, DEMA mission, career advancement tips, medical affairs professionals, diversity in medical affairs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Fierce Pharma Engage 2025 - RECAP
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellett

Fierce Pharma Engage 2025 - RECAP

Podcast
Time Audit: YOUR Strategy for Time Management Success
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellett

Time Audit: YOUR Strategy for Time Management Success

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Explore OVN